AVEO制药 AVEO 深 沪
已收盘 01-19 16:00:00 美东时间
15.00
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 15.00
- 总市值 5.21亿
- 52周最高 15.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.06
- 委 比 0.00%
- 总股本 3476.31万
- 历史最高 189.30
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.23
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aveanna Announces Second Quarter 2025 Earnings Release Date and Conference Call
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced on July 17, 2025, that it will release its second quarter 2025 financial results before the market open on Thursday, August 7, 2025. A conference call will be held at 10:00 a.m. Eastern Time on the same day. Interested parties may join the call by dialing 1-877-407-0789 (US/Canada) or 1-201-689-8562 (international), with passcode 13754011. A replay will be available three hours after the c...
07-17 10:30
产业丨RISC-V进入汽车市场进程加速，落地仍有挑战
英飞凌成首个推出汽车级RISC-VMCU的厂商 3月，英飞凌宣布，计划在未来几年推出基于RISC-V的全新汽车微控制器，引领RISC-V技术在汽车行业的应用...
04-24 20:30
KalVista Pharmaceuticals appoints Jeb Ledell as COO
KalVista Pharmaceuticals (NASDAQ:KALV) announces the appointment of Jeb Ledell as COO. Most recently, Ledell served as COO at AVEO Oncology, an LG Chem company. Furthermore, Ledell was granted inducem...
2024-12-16 20:10
LG化学首个专有的抗癌研究候选药物进入1期临床研究
LG化学和LG化学旗下公司AVEO Oncology宣布，已在美国招募了首位患者进行LB-LR1109（NCT06332755;LG项目代码LR19155），...
2024-06-14 15:19
Pineapple Financial Inc. Hosts Third Annual Charitable 3-on-3 Basketball Tournament to Benefit MLSE Foundation
TORONTO, March 12, 2024 /PRNewswire/ - Pineapple Financial Inc. (NYSE American: PAPL), ("the Company or "Pineapple"), a tech-focused mortgage brokerage with an integrated network of partner ...
2024-03-12 20:05
LG化学头颈部癌治疗新药启动Ⅲ期临床试验
LG化学官微消息，旗下抗癌新药研发公司AVEO Pharmaceuticals将在美国正式启动头颈癌新药Ficlatuzumab的Ⅲ期临床试验（试验名称：FI...
2024-01-17 11:21
IN8bio Appoints Dr. Corinne Epperly to Board of Directors
Internationally recognized immuno-oncology and cell therapy executive with 20 y...
2023-12-07 01:00
Actinium Pharmaceuticals to Attend Bio-Europe Munich 2023
NEW YORK, Nov. 2, 2023 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced...
2023-11-03 04:15
Actinium Pharma Highlights Abstract Accepted for Poster Presentation at the SITC 38th Annual Meeting
NEW YORK, Sept. 27, 2023 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today details...
2023-09-27 21:05
Medicenna Establishes Boston Presence, Appoints Brent Meadows as Chief Business Officer, and Bolsters Management
Company to grow business development, financing and clinical leadership in Bost...
2023-08-14 19:00
